Meta Information
ID:rapamycin-topical
Name:Rapamycin
Schema Version:1.5
Alternate Names
- Sirolimus (Topical)
Active Compound
rapamycin
Intervention Type
therapeutic_agent
Delivery
Route:
topical_skin
Scope:
- local
Is Skin Health
True
Regulatory Status
- us:rx_drug
- eu:rx_drug
Indication
Focus:
healthspan
Description:
Topical rapamycin inhibits the mTOR pathway directly in skin cells, which is thought to reduce cellular senescence and promote collagen production. This local action aims to reverse or slow visible si...
Typical Protocol
- Apply a 0.001% to 0.1% concentration cream to the face or hands once daily or every other day.
Expected Cost Mean
Low Cost:
50
High Cost:
150
Cost Type:
monthly
Description:
Compounded prescription cream, typically not covered by insurance for anti-aging purposes.
Summary
Topical rapamycin inhibits the mTOR pathway directly in skin cells, which is thought to reduce cellular senescence and promote collagen production. This local action aims to reverse or slow visible signs of skin aging, such as wrinkles and loss of volume, without the systemic side effects of oral rapamycin.
Purpose
Locally inhibits mTOR in skin to reduce signs of aging.
Card Summary
A topical cream that inhibits the mTOR pathway in the skin to reduce wrinkles and improve skin health, with minimal systemic absorption.
Drug Class
mtor-inhibitors
Drugs In Class
Empty Array
Impact
Score:
3.5
Justification:
Localized cosmetic benefits on skin aging; no evidence for systemic healthspan impact.
Evidence
Grade:
B
Score:
5.5
Justification:
Small human RCTs demonstrate reduced markers of skin aging and improved appearance.
Safety
Score:
3
Justification:
Minimal systemic absorption; primary risks are local skin irritation or dermatitis.
Flags
- Systemic absorption is low but not zero; potential for systemic effects is unknown long-term.
- Common side effects include localized skin irritation, redness, or dryness.
- Often requires a prescription from a compounding pharmacy, quality can vary.
- Long-term effects on skin health and skin cancer risk are not well-studied.
Verdict
Promising for skin aging, but long-term effects and safety are unproven.
Qualifier
topical, focused on healthspan
Created
2026-04-29T19:32:34.131754Z
Ai Model
Gemini 2.5 Pro (High)